Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Zebrafish help unlock mystery of motor neurone disease
Trialing 1,000 drugs on mice models would take more than 10 years, however trialling 1,000 drugs on zebrafish would take only a…
Roche-AbbVie cancer drug gets accelerated FDA approval
The drug, developed in partnership with AbbVie, was approved for patients with acute myeloid leukemia
Delivering a baby increases, then lowers, risk of breast cancer: Study
Researchers found that the breast cancer risk peaks 4.6 years after a woman’s most recent birth but then begins to fall
J&J says its psoriasis drug superior to Novartis treatment: Study
Psoriasis is a chronic condition that causes an overproduction of skin cells, resulting in inflamed, red lesions or plaques, which…
Vinod P Shah, International Chairman, SPDS, bags recognition from AAPS
Shah has conclusively demonstrated his vision, passion, and commitment to advancing treatments and cures that improve the quality…
‘We promote diversity and inclusion amongst all our clients’
Qwazent has been able to bring in leaders and healthcare practitioners from different countries for different countries. Deepali…
Blueprint for 2019
Pharma leaders and experts share their views on the trends and aspects which will shape the sector's machines, methodologies,…
DUSA Pharma awarded preliminary injunctive relief prohibiting Biofrontera from using its trade…
DUSA filed a motion for preliminary injunctive relief in November 2018 requesting an order prohibiting Biofrontera from using…
US FDA approves new protocol for study on Bayer’s birth control device
The study will now monitor here women implanted with the devices for five years, up from three years, and would need additional…
US FDA approves Stemline Therapeutics’ rare blood disease treatment
Elzonris will be commercially available in early 2019